Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

This study has suspended participant recruitment.
Sponsor:
Collaborators:
Sorrento Therapeutics, Inc.
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Dental and Craniofacial Research (NIDCR) )
ClinicalTrials.gov Identifier:
NCT00804154
First received: December 5, 2008
Last updated: June 23, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: December 2020
  Estimated Primary Completion Date: June 2020 (Final data collection date for primary outcome measure)